Parkinson's Disease and the Striatum

Excellent Video
Researchers at the Karolinska Institute recently released a video outlining their findings regarding the root causes of Parkinson's.

Highlights

•

Striatal sensory responses were studied by whole-cell recordings and optogenetics

•

Dopamine (DA) depletion affects intrinsic and sensory properties in direct pathway neurons

•

The encoding of bilateral tactile stimuli is impaired following DA depletion

•

Administration of L-DOPA can correct sensory deficits caused by DA depletion.

for more see: https://doi.org/10.1016/j.neuron.2017.05.004

This study came to my attention the researchers used our Enkaphalin Antibody as a marker for the Dopaminergic Neurons. 

Image: Mouse striatum stained with D2 cell marker Enkephalin (RA14124) in green and with neuronal marker NeuN in red courtesy of Dr Heike Rebholz of City College of New York

Dopamine and Morphine Tolerance

Dopamine Identified as Key Player

Our Mu Opioid Receptor antibody is used to show that blocking dopamine decreases morphine tolerance: Wen-Ling Dai, Feng Xiong, Bing Yan, Zheng-Yu Cao, Wen-Tao Liu, Ji-Hua Liu1, Bo-Yang Yu. Blockade of neuronal dopamine D2 receptor attenuates morphine tolerance in mice spinal cord. Scientific Reports 6, Article number: 38746 (2016). doi:10.1038/srep38746.

Images: (A) Double immunofluorescence staining showed that MOR (green) and D2DR (red) were co-localized in the mice spinal cord (20X magnification). Chronic morphine treatment increased the co-localization of MOR and D2DR in the spinal cord, and D2DR antagonist sulpiride (8 μg/10 μl, i.t.) reduced the increased co-expression of D2DR with MOR (n = 4). (B) Co-IP experiments showed that D2DR could interact with MOR, and the MOR/D2DR interactions were increased in the spinal dorsal horn after chronic morphine treatment for 7 days while D2DR antagonist sulpiride (8 μg/10 μl, i.t.) disrupted the interactions of the MOR/D2DR (n = 3).

Blockade of D2DR in spinal cord can disrupt the interactions between MOR and D2DR to attenuate morphine tolerance. These findings highlight the possibility of a new clinical strategy to prevent morphine antinociceptive tolerance.